Romiplostim, Alzheimer's drugs in large group of Japanese approvals
This article was originally published in Scrip
Executive Summary
A large group of products has received formal final approval from Japan's ministry of health, labour and welfare after a series of positive opinions over the past few months, with the new clearances including several important new therapies for rare disorders and Alzheimer's disease.